| Cas No.: | 854514-88-8 |
| Chemical Name: | N,2-dimethyl-6-[7-(2-morpholin-4-ylethoxy)quinolin-4-yl]oxy-1-benzofuran-3-carboxamide |
| Synonyms: | PF 00337210;PF00337210;PF-210;PF-337210 |
| Formula: | C26H27N3O5 |
| M.Wt: | 461.518 |
| Purity: | >98% |
| Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | A potent, selective, ATP-competitive and orally bioavailable inhibitor of VEGFR-2 with Ki of 0.7 and 8.8 nM for unactivated and fully phosphorylated VEGFR-2, respectively; inhibits the autophosphorylation of human and murine VEGFR-2 with IC50 of 0.87 nM and 0.83 nM, respectively; is less potent against KIT (9.6 nM), CSF1-R (13 nM), PDGFR-α (11 nM) and PDGFR-β (29 nM), and does not inhibit Flt-3 (>10 uM); shows dose-dependent anti-tumor efficacy in preclinical tumor models.Solid TumorsPhase 1 Clinical |

To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
